Prachi Mann

Prachi Mann

Auto-generated profile, based on publicly available information

Prachi Mann

Department of Internal Medicine, AdventHealth Orlando, Orlando, FL

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2025 in ACG Case Reports Journal
Verified
Journal Article
Open access
PMPrachi Mann
Prachi Mann
TATareq Alsaleh
Tareq Alsaleh
NSNouman Shafique
Nouman Shafique
MAMohamad Khaled Almujarkesh
Mohamad Khaled Almujarkesh
BFBaha Aldeen Bani Fawwaz
Baha Aldeen Bani Fawwaz
IIIrteza Inayat
Irteza Inayat
Hydrogen peroxide (H 2 O 2 ) is a caustic agent capable of causing serious gastrointestinal injury, yet its use as an enema is promoted in some alternative medicine communities for constipation. We report a case of a 56-year-old man who developed portal and mesenteric venous air embolism and chemical colitis following self-administration of an H 2 O 2 enema. Imaging revealed extensive portal venous gas and colitis. Colonoscopy confirmed diffuse mucosal injury, and biopsies showed acute colitis with ulceration. The patient was treated with intravenous fluids, broad-spectrum antibiotics, and hyperbaric oxygen therapy, resulting in resolution of gas embolism. This case highlights the dangers of H 2 O 2 enemas and the potential role of hyperbaric therapy in management.

30 June 2026 in ACG Case Reports Journal
Verified
Journal Article
Open access
SHSana Hussain
Sana Hussain
FBFelix Primo Radegonde Balak
Felix Primo Radegonde Balak
AMAiken Muratova
Aiken Muratova
AHAzhar Hussain
Azhar Hussain
FAFnu Aperna
Fnu Aperna
RCRicardo Conti
Ricardo Conti
Anti-Hu paraneoplastic neurological syndromes are most commonly associated with small-cell lung cancer and are rarely reported in colorectal malignancy. A 43-year-old man presented with progressive sensory neuropathy and weight loss. Evaluation revealed positive serum anti-Hu antibodies, markedly elevated cerebrospinal fluid protein, and imaging demonstrating an ascending colon mass. Right hemicolectomy confirmed Stage IIIA (pT3N1aM0) moderately differentiated adenocarcinoma, with mismatch repair–deficient (loss of MLH1 and PMS2) and B-Raf proto-oncogene, serine/threonine kinase wild-type tumor profile. Despite a significant family history, the patient had not undergone recommended early colorectal screening. Postoperative circulating tumor DNA was negative, and the patient was placed on active surveillance; however, neurological symptoms persisted, and immunomodulatory therapy access was initially limited. This case highlights a rare association between anti-Hu–associated myeloneuropathy and early-onset colon cancer and underscores the importance of malignancy evaluation in unexplained sensory neuronopathy.

15 August 2025 in Gastrointestinal Disorders
Verified
Journal Article
Open access
PDF file
TATareq Alsaleh
Tareq Alsaleh
PMPrachi Mann
Prachi Mann
JGJohn George
John George
Background: Magnetically controlled capsule endoscopy (MCCE) has shown promise in upper gastrointestinal evaluation and is a potentially less invasive alternative to esophagogastroduodenoscopy (EGD). We performed a systematic review and meta-analysis aiming to measure its diagnostic performance compared to EGD for esophageal varices. Methods: Our protocol was registered on PROSPERO (CRD420251081967). A systematic search of multiple databases was conducted through July 2025 for studies assessing the diagnostic performance of MCCE compared to EGD for EV. The primary outcomes were sensitivity and specificity. Secondary outcomes included the area under the curve (AUC), likelihood ratios, diagnostic odds ratio, and safety. Pooled effect estimates were calculated using a random effects model and expressed as proportions with 95% confidence intervals (CI). Heterogeneity was assessed using the I2 statistic. Results: Five prospective studies with 795 patients (68.8% male, mean age of 55.1) were included. The pooled sensitivity and specificity were 87.1% (95% CI: 68.5–95.4) and 95.2% (95% CI: 88.4–98.1), respectively, with an AUC of 0.97. Following subgroup analysis of cirrhotic patients, pooled sensitivity and specificity were 96.0% (95% CI: 93.6–97.5; I2 = 43%) and 95.2% (95% CI: 84.2–98.6; I2 = 88.4%), respectively. Furthermore, MCCE use with detachable strings increased sensitivity to 96% (95% CI: 93.7–97.5; I2 = 0%) and specificity to 96.3% (95% CI: 87.2–99.0; I2 = 76.8%). Only four adverse events occurred across the five studies. Conclusions: Our meta-analysis demonstrated the high sensitivity, specificity, and diagnostic accuracy of MCCE, along with a favorable safety profile. Further large-scale trials are needed to validate our findings.

6 February 2025 in Cureus
Verified
Journal Article
Open access
PDF file
WLWeiying Li
Weiying Li
PMPrachi Mann
Prachi Mann
IHIvonne De La Hoz
Ivonne De La Hoz
ACAlexa Constantakos
Alexa Constantakos
DGDwayne Gordon
Dwayne Gordon
EMEdward Maharam
Edward Maharam
Establishing the diagnosis of miliary tuberculosis (TB) can be challenging due to the heterogeneous clinical presentations and low sensitivity of diagnostic tests. Miliary TB shares overlapping clinical, radiological, and histopathological features with other chronic granulomatous diseases, such as sarcoidosis, often posing a significant diagnostic challenge for clinicians. A 36-year-old male from Haiti presented with a four-month history of recurrent fever, dry cough, night sweats, and weight loss. Chest imaging revealed innumerable widespread miliary nodules throughout the lungs bilaterally, raising a high clinical suspicion for miliary TB. The work-up for bacterial, fungal, and viral infection was negative, and there was no evidence of malignancy. Surprisingly, extensive TB testing yielded negative results. The interferon-gamma release assay (QuantiFERON TB Gold Plus®), Mycobacterium tuberculosis (MTB) complex polymerase chain reaction (PCR), and repetitive sputum cultures for acid-fast bacilli (AFB) were all negative. A lung biopsy was performed due to an unexpectedly negative tuberculosis work-up and revealed non-necrotizing granulomatous inflammation, with no AFB identified on bronchoalveolar lavage (BAL) or histopathological staining. Additionally, the next-generation sequencing technique was conducted using microbial cell-free DNA and was negative for tuberculosis or any other pathogen. Therefore, sarcoidosis was considered the most likely diagnosis based on the exclusion of infectious etiologies. The patient was started on high-dose steroids. However, the patient failed to respond clinically and developed worsening transaminitis, uptrending ferritin, and pancytopenia. His H-score was as high as 256 points, which suggested the probability of hemophagocytic lymphohistiocytosis (HLH) was as high as 99%. A bone marrow biopsy revealed multiple small foci of noncaseating granulomatous inflammation with hemophagocytic cells. The patient was started on etoposide steroids and empiric broad-spectrum antibiotics. Despite aggressive management, the patient’s condition rapidly deteriorated as he developed acute hypoxic respiratory failure requiring mechanical ventilation, refractory shock, and multi-organ failure. The infection screen was repeated due to the worsening clinical status. To everybody’s surprise, the repeated next-generation sequencing on hospital day 26 detected MTB complex. This was confirmed with positive AFB staining, MTB complex PCR, and AFB cultures on BAL samples. A four-drug anti-TB regimen was promptly commenced. However, the patient's condition continued to deteriorate rapidly, and the patient expired one week later. This complex case raised several diagnostic and therapeutic dilemmas. First of all, the optimal treatment approach remains unclear, considering the risk of infection secondary to immunosuppressants for HLH might outweigh the benefits. It also highlights the diagnostic limitations of TB testing and the overreliance on diagnostic tests that should be avoided, especially when there is a high pretest probability of miliary TB. Early initiation of empirical anti-TB therapy should be considered to improve outcomes, considering the mortality of miliary TB is extremely high.